Abstracts tagged "Economics and systemic lupus erythematosus (SLE)"

Abstract Number: 3168 • 2016 ACR/ARHP Annual Meeting
Economic Evaluation of Damage Accrual in an International SLE Inception Cohort
Megan Barber¹, Ian N. Bruce², Murray Urowitz³, John G. Hanly⁴, Li Su⁵, Juanita Romero-Diaz⁶, Caroline Gordon⁷, Sang-Cheol Bae⁸, Sasha Bernatsky⁹, Daniel J Wallace¹⁰, Joan T. Merrill¹¹, David A. Isenberg¹², Anisur Rahman¹³, Ellen M. Ginzler¹⁴, Michelle Petri¹⁵, Mary Anne Dooley¹⁶, Paul R. Fortin¹⁷, Dafna D. Gladman¹⁸, Jorge Sanchez-Guerrero¹⁹, Kristján Steinsson²⁰, Rosalind Ramsey-Goldman²¹, M Khamashta²², Cynthia Aranow²³, Graciela S. Alarcon²⁴, Barri J. Fessler²⁵, Susan Manzi²⁶, Ola Nived²⁷, Andreas Jönsen²⁸, Asad Zoma²⁹, Ronald F. van Vollenhoven³⁰, Manuel Ramos-Casals³¹, Guillermo Ruiz-Irastorza³², S. Sam Lim³³, Kenneth C. Kalunian³⁴, Murat Inanc³⁵, Diane L. Kamen³⁶, Christine A. Peschken³⁷, Søren Jacobsen³⁸, Anca Askanase³⁹, Jill P. Buyon⁴⁰, Chris Theriault⁴¹, Vernon Farewell⁴² and Ann E. Clarke⁴³, ¹Division of Rheumatology, University of Calgary, Caglary, AB, Canada, ²Central Manchester University Hospital NHS Foundation Trust and Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, ³Medicine, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ⁴Rheumatology, Division of Rheumatology, Capital Health and Dalhousie University, Halifax, NS, Canada, ⁵Nova Scotia Rehab Site, Division of Rheumatology, Capital Health and Dalhousie University, Halifax, NS, Canada, ⁶Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, Mexico, ⁷NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom, ⁸Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of, ⁹Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ¹⁰Cedars-Sinai Medical Center, West Hollywood, CA, ¹¹Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ¹²Centre for Rheumatology, Division of Medicine, University College London, London, United Kingdom, ¹³Rayne Institute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom, ¹⁴Rheumatology, SUNY Downstate Medical Center, Brooklyn, NY, ¹⁵Rheumatology Division, Johns Hopkins University School of Medicine, Baltimore, MD, ¹⁶Dooley Rheumatology, Chapel Hill Doctors, Chapel Hill, NC, ¹⁷Rheumatology, University of Laval, Quebec, QC, Canada, ¹⁸Rheumatology, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ¹⁹Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, ²⁰Rheumatology, Univ. Hospital, Reykjavik, Iceland, ²¹FSM, Northwestern University, Chicago, IL, ²²Lupus Research Unit, Lupus Research Unit, The Rayne Institute, King's College London School of Medicine, St Thomas' Hospital, London, United Kingdom, ²³Molecular Medicine and Medicine, Hofstra Northwell School of Medicine, Hempstead, NY, ²⁴Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²⁵Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, ²⁶Lupus Center of Excellence, West Penn Allegheny Health System, Pittsburgh, PA, ²⁷Department of Rheumatology, University Hospital, Lund, Sweden, ²⁸Lund University, Department of Clinical Sciences, Rheumatology, Lund, Sweden, ²⁹Rheumatology, Hairmyres Hospital, East Kilbride, Great Britain, ³⁰Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands, ³¹Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, ³²Universidad del Pais Vasco, Servicio de Medicina Interna, Hospital de Cruces, Bizkaia, Spain, ³³Medicine, Emory University School of Medicine, Atlanta, GA, ³⁴Division of Rheumatology, Allergy & Immunology, UCSD School of Medicine Center for Innovative Therapy, La Jolla, CA, ³⁵Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ³⁶Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, ³⁷RR 149G, Univ of Manitoba, Winnipeg, MB, Canada, ³⁸Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, ³⁹Rheumatology, Columbia University Medical Center, New York, NY, ⁴⁰Medicine, New York University School of Medicine, New York, NY, ⁴¹Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada, ⁴²Medicine, Division of Rheumatology, Capital Health and Dalhousie University, Halifax, NS, Canada, ⁴³Division of Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Little is known about the association of healthcare costs with damage accrual in SLE. We describe the costs associated with damage states across the disease…
Abstract Number: 930 • 2012 ACR/ARHP Annual Meeting
Disease Burden and Cost of Illness in SLE During 8 Years Follow up
Andreas Jönsen¹, Anders A. Bengtsson², Frida Hjalte³, Minna Willim⁴, Ragnar Ingvarsson¹, Ulf Persson⁵, Ingemar F. Petersson⁶ and Ola Nived⁷, ¹Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden, ²Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden, ³The Swedish Institute for Health Economics,, Health Economy, Lund, Sweden, ⁴Department of Clinical Sciences Malmö, Section of Rheumatology, Lund University, Malmö, Sweden, ⁵The Swedish Institute for Health Economics,, Lund, Sweden, ⁶Musculoskeletal Scienes, Department of Orthopedics, Clinical Sciences, Lund, Sweden, ⁷Department of Clinical Science, Lund University, Rheumatology, Lund, Sweden
Background/Purpose: To study the annual direct and indirect costs in SLE in a cohort, from a defined area in southern Sweden, and to find potential…